BACKGROUND Pertussis vaccination in infancy has been suggested to increase the risk for development of asthma and allergy. OBJECTIVE To assess sensitization rates and development of atopic diseases in a prospective randomized controlled trial of pertussis vaccine. PATIENTS AND METHODS A total of 669 children were randomized to 1 of 4 vaccine groups (2-component acellular pertussis, 5-compon...

Determination of seroconversion and measurement of protective antibody levels in children against vaccine components are essential for gauging and monitoring the efficacy of paediatric vaccination programmes. For this purpose, we assessed the combined toxin-binding inhibition (ToBI) test for determining neutralizing antibodies to tetanus and diphtheria in a diphtheria-pertussis-tetanus (DPT) va...

OBJECTIVE To assess the immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Hib polysaccharide-conjugate vaccine booster. DESIGN, SETTING AND PARTICIPANTS A DTaP-IPV//PRP~T vaccine (Pentaxim, a Sanofi Pasteur AcXim family vaccine) was given to 182 healthy children in South Africa at 18 - 19 months of age following priming with the same ...

BCG, the attenuated strain of Mycobacterium bovis, has been widely used as a vaccine against tuberculosis and is thus an important candidate as a live carrier for multiple antigens. With the aim of developing a recombinant BCG (rBCG) vaccine against diphtheria, pertussis, and tetanus (DPT), we analyzed the potential of CRM(197), a mutated nontoxic derivative of diphtheria toxin, as the recombin...

In this issue of Pediatrics Acosta et al present a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis, adsorbed (Tdap) vaccine effectiveness study in adolescents in Washington State during the first 6 months of 2012. Their findings support the previous Tdap effectiveness data from Wisconsin. The duration of Tdap effectiveness is disappointing, particularly because case-control s...

The Advisory Committee on Immunization Practices recommends administering diphtheria, tetanus and acellular pertussis (DTaP) vaccines to children at 2, 4, 6, 15-18 months, and 4-6 y of age; preferably with the same-brand vaccine for the whole series. We estimated age-appropriate DTaP dose completion and the proportion of children receiving a "mixed" DTaP vaccination series (ie, including DTaP v...

Diphtheria and tetanus toxoids have been combined with pertussis antigens and used as a combination DTP vaccine since the 1940s. More recently, this DTP combination has been used as the basis for the development of combination vaccines containing additional vaccine antigens added singly or in additional combinations such as Haemophilus influenzae type b, hepatitis B and inactivated poliovirus, ...

32 Maternal pertussis vaccination is associated with higher levels of pertussis 33 antibodies at birth. We assessed the persistence of pertussis antibodies until 34 primary vaccination in infants whose mothers received Tdap (tetanus, 35 diphtheria, acellular pertussis) vaccine during pregnancy. Infants were born at 36 the Hospital Clinic of Barcelona (Spain) in November 2014. Anti-PT IgG was 37...

background and objectives: tetanus and diphtheria are vaccine-preventable, infectious diseases with significant morbidity and mortality. immunization by the diphtheria and tetanus toxoid (dt) has been applied in iran for almost 50 years. however, there are very few data about the rate of immunity to these diseases in the adult population. the humoral immunity to tetanus and diphtheria among blo...

Prophylactic immunisation against infectious disease has been the most successful medical intervention yet in reducing mortality. From the introduction of vaccination against smallpox at the end of the eighteenth century, there has been continuous progress in producing safe and effective vaccines against a number of common diseases. These vaccines were bacterial toxoids (diphtheria and tetanus)...